This list is an analysis based on recent market events. It's not an investment recommendation.
About
Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
The current price of ISOFOL.ST is SEK0.67 SEK — it has decreased by -1.03% in the past 24 hours. Watch Isofol Medical AB stock price performance more closely on the chart.
What is Isofol Medical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Isofol Medical AB stocks are traded under the ticker ISOFOL.ST.
Is Isofol Medical AB stock price growing?▼
ISOFOL.ST stock has risen by +2.12% compared to the previous week, the month change is a -2.46% fall, over the last year Isofol Medical AB has showed a -67.57% decrease.
What is Isofol Medical AB market cap?▼
Today Isofol Medical AB has the market capitalization of 189.19M
When is the next Isofol Medical AB earnings date?▼
Isofol Medical AB is going to release the next earnings report on May 19, 2026.
What is Isofol Medical AB revenue for the last year?▼
Isofol Medical AB revenue for the last year amounts to 0 SEK.
What is Isofol Medical AB net income for the last year?▼
ISOFOL.ST net income for the last year is -149.73M SEK.
How many employees does Isofol Medical AB have?▼
As of April 03, 2026, the company has 6 employees.
In which sector is Isofol Medical AB located?▼
Isofol Medical AB operates in the Health Care sector.
When did Isofol Medical AB complete a stock split?▼
Isofol Medical AB has not had any recent stock splits.
Where is Isofol Medical AB headquartered?▼
Isofol Medical AB is headquartered in Gothenburg, SE.